Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Blood

• Publication date

  1992-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V80.11.2817.2817PMID 1450408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid

  2005cited by this paper
• Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells

  2004cited by this paper
• Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.

  1992cited by this paper
• A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

  1992cited by this paper
• Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

  1992cited by this paper
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

  1992cited by this paper
• Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells.

  1992cited by this paper
• Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells

  1992cited by this paper
• Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.

  1992cited by this paper
• Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.

  1992cited by this paper
• Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.

  1992cited by this paper
• Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes.

  1992cited by this paper
• Interleukin 2‐dependent activation of tumor‐specific cytotoxic T lymphocytes in vivo

  1991cited by this paper
• Interleukin 7 induces CD4+ T cell-dependent tumor rejection

  1991cited by this paper
• MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.

  1991cited by this paper
• A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

  1991cited by this paper
• Autologous Tumor-Specific Cytotoxicity of Tumor-Infiltrating Lymphocytes Derived from Human Renal Cell Carcinoma

  1991cited by this paper
• Active Specific Immunotherapy in the Treatment of Patients with Cancer

  1991cited by this paper
• Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

  1990cited by this paper
• Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity

  1990cited by this paper
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.

  1990cited by this paper
• Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.

  1990cited by this paper
• Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.

  1990cited by this paper
• Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.

  1989cited by this paper
• Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

  1989cited by this paper
• Murine interleukin-4 displays potent anti-tumor activity in vivo.

  1989cited by this paper
• Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.

  1989cited by this paper
• Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

  1989cited by this paper
• The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.

  1989cited by this paper
• HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.

  1989cited by this paper
• Highly efficient action of autocrine mouse interferon‐γ expressed via a retroviral vector

  1988cited by this paper
• Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity

  1988cited by this paper
• Construction and use of a safe and efficient amphotropic packaging cell line.

  1988cited by this paper
• A safe packaging line for gene transfer: separating viral genes on two different plasmids

  1988cited by this paper
• Expression of a Cloned Human Interleukin-2 cDNA Is Enhanced by the Substitution of a Heterologous mRNA Leader Region

  1988cited by this paper
• Interferon receptors.

  1988cited by this paper
• Highly efficient action of autocrine mouse interferon-gamma expressed via a retroviral vector.

  1988cited by this paper
• Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.

  1988cited by this paper
• Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells

  1987cited by this paper
• The Human Interferon‐γ Receptor System

  1987cited by this paper
• Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

  1987cited by this paper
• Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood

  1987cited by this paper
• Effect of PHA-activated T cells on B-cell differentiation.

  1986cited by this paper
• Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

  1985cited by this paper
• Adoptive immunotherapy of newly induced murine sarcomas.

  1985cited by this paper
• Clonal analysis of cytotoxic T‐lymphocyte response to autologous human metastatic melanoma

  1985cited by this paper
• The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines

  1985cited by this paper
• Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.

  1984cited by this paper
• Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

  1984cited by this paper
• Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon

  1984cited by this paper
• Differential regulation of HLA‐DR mRNAs and cell surface antigens by interferon.

  1983cited by this paper
• Clonal analysis of cytotoxic T cell response against human melanoma

  1983cited by this paper
• Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cells

  1983cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Functional and antigenic properties of cultured T cells in the cell mediated lympholysis (CML) assay.

  1982cited by this paper
• Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

  1982cited by this paper
• Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells

  1982cited by this paper
• Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells

  1982cited by this paper
• Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.

  1980cited by this paper
• Cell‐mediated cytotoxicity for cultured autologous melanoma cells

  1979cited by this paper
• In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.

  1979cited by this paper
• Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells.

  1977cited by this paper
• Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors

  1972cited by this paper

• Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development

  2012cites this paper
• Viral Vectors for Gene Transfer

  2012cites this paper
• antibodies in combination with bivalent CD28 antibodies leukemia by autologous T cells activated with CD3 x CD19 bispecific Lysis of malignant B cells from patients with B-chronic lymphocytic

  2011cites this paper
• T cell cancer immunotherapy: Characterisation and manipulation of tumour antigen-specific T cell subsets for adoptive immunotherapy in mouse models

  2011cites this paper
• Cancer vaccine development: designing tumor cells for greater immunogenicity.

  2010cites this paper
• Dendritic cells as therapeutic agents against cancer.

  2010cites this paper
• Interleukin-2 gene transfer potentiates the α-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma

  2009cites this paper
• Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma

  2009cites this paper
• hand-held gene gun I. Effect of IL-12 plus TNF-α gene

  2008cites this paper
• Genetically modified cellular vaccines for therapy of human papilloma virus type 16 (HPV 16)-associated tumours.

  2008cites this paper
• Gene therapy of cancer by vaccines carrying inserted immunostimulatory genes.

  2007cites this paper
• Discovery and development of therapeutic cancer vaccines.

  2007cites this paper
• Transduction of murine and human tumors using recombinant adenovirus vectors

  2006cites this paper
• IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.

  2005cites this paper
• Interleukin-2 gene therapy of residual EL-4 leukaemia potentiates the effect of cyclophosphamide pretreatment

  2005cites this paper
• Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells

  2004cites this paper
• Breast cancer gene therapy: transgenic immunotherapy

  2004cites this paper
• therapeutic vaccines for colorectal cancer

  2004cites this paper
• ALLOGENIC VACCINE AND METHOD TO SYNTHESIZE SAME-European Patent Office-EP 0684831 B1

  2003cites this paper
• Vectores adenovirales de primera generación, el vector por excelencia en inmunoterapia génica del cáncer

  2003cites this paper
• TRANSGENIC IL-2 EXPRESSION IN EWING TUMOR CELL LINES AFTER TRANSFECTION WITH STARBURST DENDRIMERS AND CATIONIC LIPOSOMES

  2002cites this paper
• Development and use of viral vectors for gene transfer: lessons from their applications in gene therapy

  2002cites this paper
• A brief overview of the tumor vaccines through the last decade

  2002cites this paper
• Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications.

  2000cites this paper
• Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity

  2000cites this paper
• Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.

  2000cites this paper
• Therapeutic efficiency of IL-2 gene transduced tumor vaccine for head and neck carcinoma.

  2000cites this paper
• Cytokine therapy for cancer.

  2000cites this paper
• Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter gene

  2000cites this paper
• Cytokines (IFNs, TNF-alpha, IL-2 and IL-12) and animal models of cancer.

  1999cites this paper
• Cells and cytokines in immunotherapy and gene therapy of cancer.

  1999cites this paper
• CD80 and IL-2 signals cooperate in the regression of tumors transplanted in congenitally athymic mice.

  1999cites this paper
• Development and application of adenoviral vectors for gene therapy of cancer

  1999cites this paper
• Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector.

  1999cites this paper
• Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.

  1999cites this paper
• Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.

  1999cites this paper
• Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder

  1999cites this paper
• Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.

  1998cites this paper
• Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes.

  1998cites this paper
• A defective retroviral vector encoding human interferon-alpha2 can transduce human leukemic cell lines.

  1998cites this paper
• Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor.

  1998cites this paper
• [Basic studies on IL-2 gene therapy for head and neck carcinoma].

  1998cites this paper
• Tumor Necrosis Factor-α and Interferon-γ, but not HTLV-I Tax, are Likely Factors in the Epidermotropism of Cutaneous T-Cell Lymphoma via Induction of Interferon-Inducible Protein-10

  1998cites this paper
• Impaired tumorigenicity and decreased liver metastasis of murine neuroblastoma cells engineered to secrete interleukin-2 or granulocyte macrophage colony-stimulating factor.

  1998cites this paper
• Natural killer cells and tumor therapy.

  1998cites this paper
• Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition.

  1998cites this paper
• Introduction of cytokine genes into rat solid neoplasms with a hand-held gene gun

  1998cites this paper
• Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cells.

  1998cites this paper
• Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transfected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment

  1998cites this paper
• Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.

  1998cites this paper
• Irradiated IL-2 gene-modified plasmacytoma vaccines are more efficient than live vaccines.

  1998cites this paper
• Cytokine gene transduction in the immunotherapy of cancer.

  1997cites this paper
• The role of adoptive immunotherapy in solid cancers.

  1997cites this paper
• Adenoviral vectors: development and application.

  1997cites this paper
• Construction and Characterization of Retroviral Vectors for Interleukin‐2 Gene Therapy

  1997cites this paper
• The role of the bystander effect in suicide gene therapy.

  1997cites this paper
• Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.

  1997cites this paper
• Active Immunotherapy in Melanoma Patients: New Experiences at National Cancer Institute of Milan

  1997cites this paper
• Gene therapy for cancer: what have we done and where are we going?

  1997cites this paper
• Growth factors and cytokines in tumor invasion and metastasis

  1997cites this paper
• Immunological gene therapy approaches for malignant melanoma. 2. Preclinical studies and clinical strategies.

  1997cites this paper
• Immunological gene therapy approaches for malignant melanoma. 1. Tumor-immunological background.

  1997cites this paper
• Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development

  1997cites this paper
• In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector.

  1996cites this paper
• Human somatic cell gene therapy

  1996cites this paper
• Interleukin 2 in the management of acute leukaemia.

  1996cites this paper
• Interferon γ (IFNγ) gene transfer of an EMT6 tumor that is poorly responsive to IFNγ stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC

  1996cites this paper
• Human lung carcinoma cells engineered to release IL2, IL7, GM-CSF and TNF alpha.

  1996cites this paper
• Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.

  1996cites this paper
• Inhibition of peritoneal dissemination of colon carcinoma in syngeneic mice immunized with interleukin-2-producing cells.

  1996cites this paper
• Vaccine therapy for malignant melanoma

  1996cites this paper
• Study of irradiation effects on cytokine secretion from retrovirally-transduced tumor cells: a model for tumor vaccination.

  1996cites this paper
• Expression of interleukin-4 in colon 26 cells induces both eosinophil mediated local tumor killing and T-cell mediated systemic immunity in vivo.

  1996cites this paper
• Interleukin-2 Secretion by Transduced and Unselected BDL-2 Lymphoma Results in Increased Survival in Mice with Previously Established Disseminated Disease

  1996cites this paper
• Murine colon carcinoma cells engineered to produce human interleukin‐2 induce tumor‐specific anti‐tumor response

  1996cites this paper
• Is There a Role for Interleukin-2 Gene Transfer in the Management of Acute Leukemia?

  1996cites this paper
• Cytokine gene-modified vaccines in the therapy of cancer.

  1996cites this paper
• Current immunotherapy for melanoma.

  1996cites this paper
• Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.

  1996cites this paper
• Interleukin 2 in the management of acute leukaemia

  1996cites this paper
• Therapeutic potential of retroviral vectors

  1996cites this paper
• Acute Leukaemia

  1996cites this paper
• Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells

  1996cites this paper
• Cytokines in animal models of cancer

  1996cites this paper
• Rapid Production of Interleukin-2-Secreting Tumor Cells by Herpes Simplex Virus-Mediated Gene Transfer: Implications for Autologous Vaccine Production

  1996influential citation
• Immunotherapy and Gene Therapy for Genitourinary Malignancies

  1996cites this paper
• Section Review—Oncologic, Endocrine & Metabolic: Gene Therapy Strategies for Cancer

  1995cites this paper
• Advances in cancer gene therapy.

  1995cites this paper
• Efficient transduction of early passage human melanoma to secrete IL-4.

  1995cites this paper
• Imaging the expression of transfected genes in vivo.

  1995cites this paper
• RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.

  1995cites this paper
• Gene therapy of cancer

  1995cites this paper
• Cytokine gene-modified vaccines for immunotherapy of cancer (review).

  1995cites this paper
• Treatment of metastatic malignant melanoma.

  1995cites this paper
• Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues.

  1995cites this paper
• Phase I Study of Transfected Cancer Cells Expressing the Interleukin-2 Gene Product in Limited Stage Small Cell Lung Cancer. University of Miami, Miami, Florida

  1995cites this paper
• [Future of malignant stage I melanoma. Immunology and immunotherapy].

  1995cites this paper
• A Human Melanoma Cell Line Transduced with an Interleukin-4 Gene by a Retroviral Vector Releases Biologically Active IL-4 and Maintains the Original Tumor Antigenic Phenotype

  1995cites this paper
• Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma.

  1995cites this paper
• IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.

  1995cites this paper